Scholarlink

Purpose of Review <p>The prevalence of aortic stenosis (AS) is increasing as the population ages, particularly among adults over 65 years old [1]. Despite advances in the treatment of severe AS, including transcatheter aortic valve replacement (TAVR), disparities in diagnosis, referral, and treatment persist across sex, racial, and socioeconomic groups. This review summarizes the current evidence regarding disparities in valvular heart disease (VHD) diagnosis and AS treatment, highlights barriers that contribute to inequitable access to valve replacement therapies and examines the potential of system-level interventions to improve equity in care delivery.</p> Recent Findings <p>Persistent disparities in AS care have been documented across multiple stages of the care pathway, including disease recognition, specialist referral, and receipt of aortic valve replacement (AVR). We present findings from a pragmatic randomized quality improvement intervention evaluating electronic provider notifications (EPNs) designed to improve recognition and treatment of severe AS. In a cluster-randomized trial, EPNs significantly increased rates of AVR, improved survival among symptomatic patients, and eliminated observed sex-based disparities within this study [2].</p> Summary <p>Despite the availability of effective therapies for severe AS, including TAVR, inequities in diagnosis and treatment remain substantial. Findings from the EPN trial suggest that system-level interventions integrated into routine clinical workflows may represent scalable strategies for improving both quality and equity in the delivery of life-saving therapies for severe AS [2].</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Have we Made Progress in Ensuring Equitable Penetration of TAVR Among Diverse Patient Populations? If not, Why?

  • 期刊论文

  • 发表日期：

    2026年7月4日

查看全文
  • Trinity Hart,
  • Nimra Gilani,
  • Rimsky Denis,
  • Oluseun Alli,
  • Uzoma Ibebuogu,
  • Jeremy Rier,
  • Icilma Fergus,
  • Kevin F. Kwaku,
  • Cassandra McCullough,
  • Sue Peschin,
  • Aaron Horne Jr.

摘要

Purpose of Review

The prevalence of aortic stenosis (AS) is increasing as the population ages, particularly among adults over 65 years old [1]. Despite advances in the treatment of severe AS, including transcatheter aortic valve replacement (TAVR), disparities in diagnosis, referral, and treatment persist across sex, racial, and socioeconomic groups. This review summarizes the current evidence regarding disparities in valvular heart disease (VHD) diagnosis and AS treatment, highlights barriers that contribute to inequitable access to valve replacement therapies and examines the potential of system-level interventions to improve equity in care delivery.

Recent Findings

Persistent disparities in AS care have been documented across multiple stages of the care pathway, including disease recognition, specialist referral, and receipt of aortic valve replacement (AVR). We present findings from a pragmatic randomized quality improvement intervention evaluating electronic provider notifications (EPNs) designed to improve recognition and treatment of severe AS. In a cluster-randomized trial, EPNs significantly increased rates of AVR, improved survival among symptomatic patients, and eliminated observed sex-based disparities within this study [2].

Summary

Despite the availability of effective therapies for severe AS, including TAVR, inequities in diagnosis and treatment remain substantial. Findings from the EPN trial suggest that system-level interventions integrated into routine clinical workflows may represent scalable strategies for improving both quality and equity in the delivery of life-saving therapies for severe AS [2].